Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A decade after the KDOQI CKD guidelines: impact on NKF-KDOQI.
Kramer H, Berns JS, Nally J, Choi MJ, Rocco MV. Kramer H, et al. Among authors: rocco mv. Am J Kidney Dis. 2012 Nov;60(5):694-6. doi: 10.1053/j.ajkd.2012.08.014. Am J Kidney Dis. 2012. PMID: 23067632 No abstract available.
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline.
Kramer HJ, Townsend RR, Griffin K, Flynn JT, Weiner DE, Rocco MV, Choi MJ, Weir MR, Chang TI, Agarwal R, Beddhu S. Kramer HJ, et al. Among authors: rocco mv. Am J Kidney Dis. 2019 Apr;73(4):437-458. doi: 10.1053/j.ajkd.2019.01.007. Am J Kidney Dis. 2019. PMID: 30905361 Free PMC article. Review.
An Endorsement of the Removal of Race From GFR Estimation Equations: A Position Statement From the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.
Kramer HJ, Jaar BG, Choi MJ, Palevsky PM, Vassalotti JA, Rocco MV; National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Kramer HJ, et al. Among authors: rocco mv. Am J Kidney Dis. 2022 Dec;80(6):691-696. doi: 10.1053/j.ajkd.2022.08.004. Epub 2022 Sep 2. Am J Kidney Dis. 2022. PMID: 36058427 No abstract available.
Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT.
Drawz PE, Lenoir KM, Rai NK, Rastogi A, Chu CD, Rahbari-Oskoui FF, Whelton PK, Thomas G, McWilliams A, Agarwal AK, Suarez MM, Dobre M, Powell J, Rocco MV, Lash JP, Oparil S, Raj DS, Dwyer JP, Rahman M, Soman S, Townsend RR, Pemu P, Horwitz E, Ix JH, Tuot DS, Ishani A, Pajewski NM. Drawz PE, et al. Among authors: rocco mv. Clin J Am Soc Nephrol. 2024 Feb 1;19(2):213-223. doi: 10.2215/CJN.0000000000000335. Epub 2023 Oct 25. Clin J Am Soc Nephrol. 2024. PMID: 37883184 Clinical Trial.
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.
Bullen AL, Katz R, Lee AK, Anderson CAM, Cheung AK, Garimella PS, Jotwani V, Haley WE, Ishani A, Lash JP, Neyra JA, Punzi H, Rastogi A, Riessen E, Malhotra R, Parikh CR, Rocco MV, Wall BM, Bhatt UY, Shlipak MG, Ix JH, Estrella MM. Bullen AL, et al. Among authors: rocco mv. Kidney Int. 2019 Aug;96(2):470-479. doi: 10.1016/j.kint.2019.03.024. Epub 2019 May 7. Kidney Int. 2019. PMID: 31262489 Free PMC article. Clinical Trial.
197 results